Increase in fiber density for immunoreactive serotonin, substance P, enkephalin and thyrotropin-releasing hormone occurs during the early presymptomatic period of motoneuron disease in Wobbler mouse spinal cord ventral horn

被引:3
作者
Bose, P
Vacca-Galloway, LL
机构
[1] Univ Florida, Inst Brain, Dept Neurosci, Gainesville, FL 32610 USA
[2] Univ Hong Kong, Fac Med, Dept Anat, Hong Kong, Peoples R China
关键词
sprouting; immunocytochemistry; motoneuron loss; neuropeptides;
D O I
10.1016/S0304-3940(98)00959-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The Wobbler mouse is a useful small animal model for the study of human motoneuron diseases. Besides showing the loss of motoneurons when the symptoms are expressed around the age of 3 weeks, we have also demonstrated the presumed 'sprouting' of neuronal processes in the cervical spinal ventral horn which contain immunoreactive (IR) serotonin (5-HT), substance P (SP) and methionine and leucine enkephalins (ME, LE), as well as thyrotropin-releasing hormone (TRH). This occurs during the symptomatic period when IR-5-HT, ME and LE sprout at Stage 1, around the age of 3 weeks, whereas IR-SP sprouts only at a late stage (stage 4) of the disease (at age 3 months). The present investigation shows that the presumed sprouting occurs even before the appearance of symptoms and prior to significant motoneuron losses. IR-5-HT containing neuronal processes sprout by postnatal day 7, whereas IR-SP, -ME, -LE, and -TRH processes sprout by day 14. Hypothetically the early sprouts may contribute to the loss of motoneurons. They also respond to ciliary and brain derives neurotrophic factors cotreatment. IR-SP neuronal processes, although they sprout by day 14, show normal fiber density by the time symptoms appear (stage 1, age 21 days). However the SP sprouting is biphasic and a significant increase in number also occurs at an advanced stage of the disease (stage 4, age 3 months). (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 21 条
[1]  
Andrews J.M., 1976, AMYOTROPHIC LATERAL, P181
[2]   A novel behavioral method to detect motoneuron disease in Wobbler mice aged three to seven days old [J].
Bose, P ;
Fielding, R ;
Ameis, KM ;
Vacca-Galloway, LL .
BRAIN RESEARCH, 1998, 813 (02) :334-342
[3]  
BOSE P, 1997, THESIS U HONG KONG
[4]   AN HEREDITARY MOTOR NEURONE DISEASE WITH PROGRESSIVE DENERVATION OF MUSCLE IN MOUSE - MUTANTWOBBLER [J].
DUCHEN, LW ;
STRICH, SJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1968, 31 (06) :535-&
[5]  
Falconer D., 1956, MOUSE NEWS LETT, V15, P23
[6]   PROTEIN-A, AVIDIN, AND BIOTIN IN IMMUNOHISTOCHEMISTRY [J].
HSU, SM ;
RAINE, L .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (11) :1349-1353
[7]   Genetic transfer of the wobbler gene to a C57BL/6J X NZB hybrid stock: Natural history of the motor neuron disease and response to CNTF and BDNF cotreatment [J].
Ishiyama, T ;
Klinkosz, B ;
Pioro, EP ;
Mitsumoto, H .
EXPERIMENTAL NEUROLOGY, 1997, 148 (01) :247-255
[8]   A THERAPEUTIC TRIAL OF GANGLIOSIDES AND THYMOSIN IN THE WOBBLER MOUSE MODEL OF MOTOR NEURON DISEASE [J].
LANGE, DJ ;
GOOD, PF ;
BRADLEY, WG .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 61 (02) :211-216
[9]   MOTONEURON LOSS IN THE ABDUCENS NUCLEUS OF WOBBLER MICE [J].
LAVAIL, JH ;
KOO, EH ;
DEKKER, NP .
BRAIN RESEARCH, 1987, 404 (1-2) :127-132
[10]  
LEESTMA JE, 1980, AM J PATHOL, V100, P821